Wiessing, Lucas and Sypsa, V and Abagiu, A O and Arble, A and Berndt, N and Bosch, A and Buskin, S and Chemtob, D and Combs, B and Conyngham, C and Feelemyer, J and Fitzgerald, M and Goldberg, D and Hatzakis, A and Patrascu, R E and Keenan, E and Khan, I and Konrad, S and Leahy, J and McAuley, A and Menza, T and Merrick, S and Metcalfe, R and Rademaker, T and Revivo, S and Rosca, P and Seguin-Devaux, C and Skinner, S and Smith, C and Tinsley, J and Wilberg, M and Des Jarlais, D (2023) Impact of COVID-19 & response measures on HIV-HCV prevention services and social determinants in people who inject drugs in 13 sites with recent HIV outbreaks in Europe, North America and Israel. AIDS and Behavior, 27, (4), pp. 1140-1153. doi: 10.1007/s10461-022-03851-x.
External website: https://link.springer.com/article/10.1007/s10461-0...
HIV/HCV prevention among people who inject drugs (PWID) is of key public health importance. We aimed to assess the impact of COVID-19 and associated response measures on HIV/HCV prevention services and socio-economic status of PWID in high-HIV-risk sites. Sites with recent (2011-2019) HIV outbreaks among PWID in Europe North America and Israel, that had been previously identified, were contacted early May 2020. Out of 17 sites invited to participate, 13 accepted. Semi-structured qualitative site reports were prepared covering data from March to May 2020, analyzed/coded and confirmed with a structured questionnaire, in which all sites explicitly responded to all 103 issues reported in the qualitative reports. Opioid maintenance treatment, needle/syringe programs and antiretroviral treatment /hepatitis C treatment continued, but with important reductions and operational changes. Increases in overdoses, widespread difficulties with food and hygiene needs, disruptions in drug supply, and increased homelessness were reported. Service programs rapidly reformed long established, and politically entrenched, restrictive service delivery policies. Future epidemic control measures should include mitigation of negative side-effects on service provision and socio-economic determinants in PWID.
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease > Viral disease / infection > Coronavirus (COVID-19)
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease > HIV
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease > Hepatitis C (HCV)
J Health care, prevention, harm reduction and treatment > Harm reduction > Substance use harm reduction
J Health care, prevention, harm reduction and treatment > Health related issues > Health information and education > Communicable / infectious disease control
J Health care, prevention, harm reduction and treatment > Health related issues > Health information and education > Communicable / infectious disease control > Needle syringe distribution and exchange
T Demographic characteristics > Person who injects drugs (Intravenous / injecting)
VA Geographic area > United States
VA Geographic area > Europe
VA Geographic area > Europe > Ireland
Repository Staff Only: item control page